Bank of the West’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | $6.06M | Buy |
118,304
+3,714
| +3% | +$178K | 0.71% | 40 |
|
|
2022
Q3 | $5.01M | Buy |
114,590
+220
| +0.2% | +$10.7K | 0.65% | 44 |
|
|
2022
Q2 | $6M | Sell |
114,370
-2,222
| -2% | -$113K | 0.76% | 38 |
|
|
2022
Q1 | $6.04M | Buy |
116,592
+5,954
| +5% | +$309K | 0.62% | 44 |
|
|
2021
Q4 | $6.53M | Buy |
110,638
+2,964
| +3% | +$147K | 0.62% | 45 |
|
|
2021
Q3 | $4.63M | Buy |
107,674
+4,634
| +4% | +$205K | 0.48% | 58 |
|
|
2021
Q2 | $4.04M | Buy |
103,040
+47
| +0% | +$1.83K | 0.41% | 67 |
|
|
2021
Q1 | $3.73M | Sell |
102,993
-12,879
| -11% | -$457K | 0.42% | 63 |
|
|
2020
Q4 | $4.27M | Sell |
115,872
-1,245
| -1% | -$45.7K | 0.5% | 57 |
|
|
2020
Q3 | $4.08M | Sell |
117,117
-10,264
| -8% | -$360K | 0.55% | 50 |
|
|
2020
Q2 | $3.95M | Sell |
127,381
-2,016
| -2% | -$68.5K | 0.53% | 57 |
|
|
2020
Q1 | $4.01M | Sell |
129,397
-24,406
| -16% | -$832K | 0.62% | 45 |
|
|
2019
Q4 | $5.72M | Sell |
153,803
-4,886
| -3% | -$174K | 0.67% | 40 |
|
|
2019
Q3 | $5.41M | Buy |
158,689
+1,222
| +0.8% | +$44.4K | 0.65% | 38 |
|
|
2019
Q2 | $6.47M | Sell |
157,467
-4,587
| -3% | -$182K | 0.76% | 36 |
|
|
2019
Q1 | $6.53M | Sell |
162,054
-25,018
| -13% | -$1M | 0.76% | 35 |
|
|
2018
Q4 | $7.75M | Sell |
187,072
-72,412
| -28% | -$3.01M | 0.93% | 27 |
|
|
2018
Q3 | $10.8M | Sell |
259,484
-1,909
| -0.7% | -$73.5K | 1.27% | 15 |
|
|
2018
Q2 | $9M | Sell |
261,393
-2,222
| -0.8% | -$75.9K | 1.1% | 19 |
|
|
2018
Q1 | $8.88M | Buy |
263,615
+1,770
| +0.7% | +$60.8K | 1.11% | 19 |
|
|
2017
Q4 | $9M | Buy |
261,845
+20,897
| +9% | +$713K | 1.13% | 18 |
|
|
2017
Q3 | $8.16M | Buy |
240,948
+8,166
| +4% | +$262K | 1.03% | 21 |
|
|
2017
Q2 | $7.42M | Buy |
232,782
+40,414
| +21% | +$1.27M | 0.95% | 26 |
|
|
2017
Q1 | $6.24M | Buy |
192,368
+18,977
| +11% | +$598K | 0.79% | 37 |
|
|
2016
Q4 | $5.34M | Buy |
173,391
+7,412
| +4% | +$226K | 0.74% | 41 |
|
|
2016
Q3 | $5.33M | Buy |
165,979
+36,274
| +28% | +$1.21M | 0.74% | 40 |
|
|
2016
Q2 | $4.33M | Buy |
129,705
+52,833
| +69% | +$1.69M | 0.62% | 49 |
|
|
2016
Q1 | $2.16M | Sell |
76,872
-17,489
| -19% | -$500K | 0.3% | 102 |
|
|
2015
Q4 | $2.89M | Sell |
94,361
-9,386
| -9% | -$295K | 0.4% | 73 |
|
|
2015
Q3 | $3.09M | Sell |
103,747
-2,766
| -3% | -$88.7K | 0.49% | 65 |
|
|
2015
Q2 | $3.39M | Sell |
106,513
-651
| -0.6% | -$21.2K | 0.48% | 67 |
|
|
2015
Q1 | $3.54M | Sell |
107,164
-934
| -0.9% | -$29.7K | 0.5% | 68 |
|
|
2014
Q4 | $3.19M | Sell |
108,098
-58
| -0.1% | -$1.66K | 0.47% | 70 |
|
|
2014
Q3 | $3.03M | Sell |
108,156
-117,472
| -52% | -$3.3M | 0.52% | 69 |
|
|
2014
Q2 | $6.35M | Buy |
225,628
+291
| +0.1% | +$8.29K | 0.99% | 28 |
|
|
2014
Q1 | $6.87M | Sell |
225,337
-657
| -0.3% | -$19.6K | 1.13% | 22 |
|
|
2013
Q4 | $6.57M | Buy |
225,994
+12,832
| +6% | +$373K | 1.04% | 23 |
|
|
2013
Q3 | $5.81M | Sell |
213,162
-2,539
| -1% | -$69.1K | 1.06% | 25 |
|
|
2013
Q2 | $5.73M | Buy |
+215,701
| New | +$5.96M | 1.08% | 25 |
|
Other funds holding PFE
AWA
Bank of the West's PFE Position: Q4 2022 in Review
Bank of the West increased its Pfizer (PFE) stake by 3.2% in Q4 2022, buying an estimated $178K and bringing the position to 118,304 shares worth $6.06M. The position accounts for 0.71% of the portfolio, ranked #40.
Bank of the West first reported a position in PFE in Q2 2013 and has held it in 39 quarters since. The position peaked at $10.8M in Q3 2018. 3,266 funds tracked by Wall St. Rank hold PFE as of Q4 2022.
- Bank of the West held 118,304 shares of Pfizer worth $6.06M as of Q4 2022.
- Bank of the West bought 3,714 Pfizer shares in Q4 2022, an estimated $178K.
- Pfizer made up 0.71% of Bank of the West's portfolio in Q4 2022, its #40 holding.
- Bank of the West first reported a position in Pfizer in Q2 2013 and has held it in 39 quarters since.
- Bank of the West's Pfizer position peaked at $10.8M in Q3 2018.
- 3,266 funds tracked by Wall St. Rank held Pfizer as of Q4 2022.
Based on Bank of the West's 13F filing for Q4 2022, filed 1 Feb 2023.